Most screenings end with a report. Ours ends with a conversation with a cancer specialist.
Risk assessment, on-site screening and specialist consultation, brought to your workplace, your community, or wherever your people are.
Oncologist-led · AI-assisted · On-site
Before, not after.
The usual route
Symptom appears
GP visit
Tests and waiting
Specialist referral
Oncologist, often later
With Intercept
While you feel well →
One-on-one with an oncologist, on-site
Fewer than 1 in 3
common cancers in India found at an early stage
| Routine health check | Intercept | |
|---|---|---|
| Who sees you | Usually a general physician | An oncologist |
| Screening | Designed for general wellness, not cancer detection | Cancer-specific, risk-based |
| Results | Often a written report | Private one-on-one consultation |
| Follow-up | Not always included | Structured next steps |
| Group reporting | Not always provided | Anonymised insights |
An on-site screening programme for White Lotus Group
90
employees screened
88
had never had a cancer screening before
12
identified as high risk
Beyond cancer screening: severe anaemia and vitamin deficiencies identified.
Prevention gap: of all the women screened, only one had received the HPV vaccine, and in consultations almost none were aware that HPV vaccination can prevent cervical cancer.
Something to keep: every employee took home a Cancer Awareness Booklet covering risk factors, warning signs, breast and oral self-examination, and HPV vaccination, to share with their families.
On-site cancer screening
Risk assessment, full physical examination including oral cancer screening, lab evaluation, thermal breast imaging, and a private consultation with an oncologist, delivered at your site.
Awareness sessions
Talks on cancer prevention, lifestyle, early warning signs and self-examination, led by an oncologist.
HPV vaccination drives
Awareness and on-site vaccination to help protect eligible women against cervical cancer.
🔒 Individual results go only to the individual. Organisations receive anonymised, group-level insights, never personal medical data.
Videos
Let's talk cancer, with Dr. Shalini.
Short educational videos on cancer screening, prevention and early detection.
Loading videos…
Dr. Shalini Kamal Kumar
Consultant Oncologist · Founder, Intercept Oncology
Intercept’s programmes are designed and led by Dr. Shalini Kamal Kumar, an oncologist with over six years in cancer care.
Tell us about your group.
Tell us your group’s size, location and timeline, and we’ll suggest a programme that fits. Enquire for programme details and pricing.
Sources. 1 in 9: Sathishkumar K, et al. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian Journal of Medical Research.
Fewer than 1 in 3: Mathur P, et al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Global Oncology, 2020. Based on 2012–2016 hospital registry data.
Fewer than 1 in 3: Mathur P, et al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Global Oncology, 2020. Based on 2012–2016 hospital registry data.